GUCY2C and Crohn disease: As impaired intestinal barrier integrity contributes to the development of the disease, we assessed the concentration of serum proguanylin, which represents the inactive and most abundant form of GC-C agonist in circulation, in patients with Crohn’s disease and healthy individuals.